.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Emerging Treatment Options for Recurrent C. Difficile Infection

Dr. Feuerstadt, a gastroenterologist, discusses foundational trials and ongoing studies in the use of fecal microbial transplantation (FMT) for treatment of recurrent C. difficile infections.

EP. 1: Clostridioides Difficile Infection Overview and Management

July 26th 2022

Dr Paul Feuerstadt provides an overview of Clostridioides difficile infection and why it is challenging to manage recurrent C diff infections (rCDI).

EP. 2: Foundational Trials for Fecal Microbial Transplantation for C Diff Infection

July 26th 2022

A gastroenterologist summarizes foundational trials that led to the use of fecal microbial transplant for treatment of rCDI.

EP. 3: Emerging Treatments for Recurrent C diff Infection

July 26th 2022

Dr Feuerstadt discusses data with 4 emerging microbiota-based live biotherapeutics for treatment of rCDI: RBX2660, SER-109, CP101, and VE303.

Latest News

Joseph Goldberg, MD: Treating Mixed Feature Depression

M. Katherine Shear, MD: Addressing Grief After a Loss

Larry Culpepper, MD: The Challenge of Treating BPD

View More News